Major erythrocyte membrane protein genes in EKLF-deficient mice

Experimental Hematology

Volumn 34, Issue 6, 2006, Pages 705-712

  Nilson, Douglas G ^a   Sabatino, Denise E ^a   Bodine, David M ^a   Gallagher, Patrick G ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; ANKYRIN; CELL MEMBRANE PROTEIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROID KRUPPEL LIKE FACTOR; FODRIN; GAMMA GLOBIN; GLOBIN MESSENGER RNA; SPECTRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ERYTHROCYTE FRAGILITY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HEMOLYSIS; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SURVIVAL; WILD TYPE;

ANIMALS; CELL NUCLEUS; EMBRYO LOSS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES, ABNORMAL; GENE EXPRESSION REGULATION; GLOBINS; HEMOLYSIS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROMOTER REGIONS (GENETICS);

ANIMALIA;

EID: 33646675621     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.02.018     Document Type: Article

References (52)

1. Bieker J.J. Kruppel-like factors: three fingers in many pies. J Biol Chem 276 (2001) 34355-34358
2. Perkins A. Erythroid Kruppel like factor: from fishing expedition to gourmet meal. Int J Biochem Cell Biol 31 (1999) 1175-1192
3. Feng W.C., Southwood C.M., and Bieker J.J. Analyses of beta-thalassemia mutant DNA interactions with erythroid Kruppel-like factor (EKLF), an erythroid cell-specific transcription factor. J Biol Chem 269 (1994) 1493-1500
4. Miller I.J., and Bieker J.J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13 (1993) 2776-2786
5. Kulozik A.E., Bellan-Koch A., Bail S., Kohne E., and Kleihauer E. Thalassemia intermedia: moderate reduction of beta globin gene transcriptional activity by a novel mutation of the proximal CACCC promoter element. Blood 77 (1991) 2054-2058
6. Orkin S.H., Antonarakis S.E., and Kazazian Jr. H.H. Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC. J Biol Chem 259 (1984) 8679-8681
7. Orkin S.H., Kazazian Jr. H.H., Antonarakis S.E., et al. Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296 (1982) 627-631
8. Armstrong J.A., Bieker J.J., and Emerson B.M. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 95 (1998) 93-104
9. Donze D., Townes T.M., and Bieker J.J. Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J Biol Chem 270 (1995) 1955-1959
10. Gillemans N., Tewari R., Lindeboom F., et al. Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the beta-globin locus control region in vivo. Genes Dev 12 (1998) 2863-2673
11. Goodwin A.J., McInerney J.M., Glander M.A., Pomerantz O., and Lowrey C.H. In vivo formation of a human beta-globin locus control region core element requires binding sites for multiple factors including GATA-1, NF-E2, erythroid Kruppel-like factor, and Sp1. J Biol Chem 276 (2001) 26883-26892
12. Harju S., McQueen K.J., and Peterson K.R. Chromatin structure and control of beta-like globin gene switching. Exp Biol Med 227 (2002) 683-700
13. Koury M.J., Sawyer S.T., and Brandt S.J. New insights into erythropoiesis. Curr Opin Hematol 9 (2002) 93-100
14. McMorrow T., van den Wijngaard A., Wollenschlaeger A., et al. Activation of the beta globin locus by transcription factors and chromatin modifiers. EMBO J 19 (2000) 4986-4996
15. Perkins A.C., Gaensler K.M., and Orkin S.H. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci U S A 93 (1996) 12267-12271
16. Tewari R., Gillemans N., Wijgerde M., et al. Erythroid Kruppel-like factor (EKLF) is active in primitive and definitive erythroid cells and is required for the function of 5′HS3 of the beta-globin locus control region. EMBO J 17 (1998) 2334-2341
17. Wijgerde M., Gribnau J., Trimborn T., et al. The role of EKLF in human beta-globin gene competition. Genes Dev 10 (1996) 2894-2902
18. Zhang P., Basu P., Redmond L.C., et al. A functional screen for Kruppel-like factors that regulate the human gamma-globin gene through the CACCC promoter element. Blood Cells Mol Dis 35 (2005) 227-235
19. Lim S.K., Bieker J.J., Lin C.S., and Costantini F. A shortened life span of EKLF-/- adult erythrocytes, due to a deficiency of beta-globin chains, is ameliorated by human gamma-globin chains. Blood 90 (1997) 1291-1229
20. Nuez B., Michalovich D., Bygrave A., Ploemacher R., and Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375 (1995) 316-318
21. Perkins A.C., Sharpe A.H., and Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375 (1995) 318-322
22. Aγ globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood 95 (2000) 1827-1833
23. Stamatoyannopoulos G., Josephson B., Zhang J.W., and Li Q. Developmental regulation of human gamma-globin genes in transgenic mice. Mol Cell Biol 13 (1993) 7636-7644
24. Behringer R.R., Hammer R.E., Brinster R.L., Palmiter R.D., and Townes T.M. Two 3′ sequences direct adult erythroid-specific expression of human beta-globin genes in transgenic mice. Proc Natl Acad Sci U S A 84 (1987) 7056-7060
25. Gallagher P.G., Romana M., Tse W.T., Lux S.E., and Forget B.G. The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter. Blood 96 (2000) 1136-1143
26. Gallagher P.G., Sabatino D.E., Romana M., et al. A human beta-spectrin gene promoter directs high level expression in erythroid but not muscle or neural cells. J Biol Chem 274 (1999) 6062-6073
27. Sabatino D.E., Wong C., Cline A.P., et al. A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. J Biol Chem 275 (2000) 28549-28554
28. Persons D.A., Allay E.R., Sabatino D.E., Kelly P., Bodine D.M., and Nienhuis A.W. Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy. Blood 97 (2001) 3275-3282
29. Gallagher P.G., Weed S.A., Tse W.T., et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. J Clin Invest 95 (1995) 1174-1182
30. Gallagher P.G., Zhang Z., Morrow J.S., and Forget B.G. Mutation of a highly conserved isoleucine disrupts hydrophobic interactions in the alpha beta spectrin self-association binding site. Lab Invest 84 (2004) 229-234
31. Aγ-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice. Mol Cell Biol 18 (1998) 6634-6640
32. Frazar T.F., Weisbein J.L., Anderson S.M., et al. Variegated expression from the murine band 3 (AE1) promoter in transgenic mice is associated with mRNA transcript initiation at upstream start sites and can be suppressed by the addition of the chicken beta-globin 5′ HS4 insulator element. Mol Cell Biol 23 (2003) 4753-4763
33. Whitney III J.B. Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochem Genet 16 (1978) 667-672
34. Hanson R.D., Connolly N.L., Burnett D., Campbell E.J., Senior R.M., and Ley T.J. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J Biol Chem 265 (1990) 1524-1530
35. Perrotta S., Borriello A., Scaloni A., et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 106 (2005) 4359-4366
36. Ribeiro M.L., Alloisio N., Almeida H., et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 96 (2000) 1602-1604
37. Ciavatta D.J., Ryan T.M., Farmer S.C., and Townes T.M. Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. Proc Natl Acad Sci U S A 92 (1995) 9259-9263
38. Rivella S., May C., Chadburn A., Riviere I., and Sadelain M. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 101 (2003) 2932-2939
39. Skow L.C., Burkhart B.A., Johnson F.M., et al. A mouse model for beta-thalassemia. Cell 34 (1983) 1043-1052
40. Yang B., Kirby S., Lewis J., Detloff P.J., Maeda N., and Smithies O. A mouse model for beta 0-thalassemia. Proc Natl Acad Sci U S A 92 (1995) 11608-11612
41. Southwood C.M., Downs K.M., and Bieker J.J. Erythroid Kruppel-like factor exhibits an early and sequentially localized pattern of expression during mammalian erythroid ontogeny. Dev Dyn 206 (1996) 248-259
42. Coghill E., Eccleston S., Fox V., et al. Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice. Blood 97 (2001) 1861-1868
43. Drissen R., von Lindern M., Kolbus A., et al. The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol 25 (2005) 5205-5214
44. Bennett V., and Baines A.J. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev 81 (2001) 1353-1392
45. Mohler P.J., and Bennett V. Defects in ankyrin-based cellular pathways in metazoan physiology. Front Biosci 10 (2005) 2832-2840
46. Gallagher P.G. Hematologically important mutations: ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 35 (2005) 345-347
47. Eber S., and Lux S.E. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 41 (2004) 118-141
48. Alper S.L. Molecular physiology of SLC4 anion exchangers. Exp Physiol 91 (2006) 153-161
49. Tanner M.J. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 9 (2002) 133-139
50. Peters L.L., Shivdasani R.A., Liu S.C., et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 86 (1996) 917-927
51. Southgate C.D., Chishti A.H., Mitchell B., Yi S.J., and Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton. Nat Genet 14 (1996) 227-230
52. Khanna R., Chang S.H., Andrabi S., et al. Headpiece domain of dematin is required for the stability of the erythrocyte membrane. Proc Natl Acad Sci U S A 99 (2002) 6637-6642